Biotech Values

[ThomasS]

TEVA/MNTA: Wouldn't the product presumably have to enter US jurisdiction in order for the FDA to prosecute the Teva aNDA? Doesn't matter where, just "if" the FDA had a sample?
On another front, wouldn't data on an infringed product, provided to the U.S. FDA, qualify as de facto infringed product?

I like the earlier analogy of MNTA going "all-in" on this and requiring Teva to either call or get up from the F------ table.